{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:30:16Z","timestamp":1790994616378,"version":"4.1.0"},"reference-count":45,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2025,7,31]]},"DOI":"10.1536\/ihj.24-712","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T22:10:05Z","timestamp":1753913405000},"page":"540-546","source":"Crossref","is-referenced-by-count":1,"title":["Difference in the Association between Growth Differentiation Factor 15 and Coronary Calcified Plaque According to Chronic Kidney Disease"],"prefix":"10.1536","volume":"66","author":[{"given":"Hayato","family":"Shimizu","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hoshide","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Funayama","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuomi","family":"Kario","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Joki N, Hase H, Nakamura R, Yamaguchi T. Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant 1997; 12: 718-23.","DOI":"10.1093\/ndt\/12.4.718"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32: S112-9.","DOI":"10.1053\/ajkd.1998.v32.pm9820470"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-63.","DOI":"10.1001\/archinte.164.6.659"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ho JE, Hwang SJ, Wollert KC, <i>et al<\/i>. Biomarkers of cardiovascular stress and incident chronic kidney disease. Clin Chem 2013; 59: 1613-20.","DOI":"10.1373\/clinchem.2013.205716"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Moe OW, Kuro-o M. Fibroblast growth factor 23 and uremic vascular calcification: Is it time to escalate from biomarker status to pathogenic agent? Kidney Int 2014; 85: 1022-3.","DOI":"10.1038\/ki.2013.471"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Feldreich T, Nowak C, Carlsson AC, <i>et al<\/i>. The association between plasma proteomics and incident cardiovascular disease identifies mmp-12 as a promising cardiovascular risk marker in patients with chronic kidney disease. Atherosclerosis 2020; 307: 11-5.","DOI":"10.1016\/j.atherosclerosis.2020.06.013"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Farquhar A, MacDonald MK, Ireland JT. The role of fibrin deposition in diabetic glomerulosclerosis: A light, electron and immunofluorescence microscopy study. J Clin Pathol 1972; 25: 657-67.","DOI":"10.1136\/jcp.25.8.657"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hertig A, Rondeau E. Role of the coagulation\/fibrinolysis system in fibrin-associated glomerular injury. J Am Soc Nephrol 2004; 15: 844-53.","DOI":"10.1097\/01.ASN.0000115400.52705.83"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Ueda S, Yamagishi S, Kaida Y, Okuda S. Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney disease. Nephrology 2007; 12: 582-90.","DOI":"10.1111\/j.1440-1797.2007.00840.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yilmaz MI, Saglam M, Caglar K, <i>et al<\/i>. The determinants of endothelial dysfunction in ckd: Oxidative stress and asymmetric dimethylarginine. Am J Kidney Dis 2006; 47: 42-50.","DOI":"10.1053\/j.ajkd.2005.09.029"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ago T, Sadoshima J. Gdf15, a cardioprotective tgf-beta superfamily protein. Circ Res 2006; 98: 294-7.","DOI":"10.1161\/01.RES.0000207919.83894.9d"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Gohar A, Gon\u00e7alves I, Vrijenhoek J, <i>et al<\/i>. Circulating gdf-15 levels predict future secondary manifestations of cardiovascular disease explicitly in women but not men with atherosclerosis. Int J Cardiol 2017; 241: 430-6.","DOI":"10.1016\/j.ijcard.2017.03.101"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kim JS, Kim S, Won CW, Jeong KH. Association between plasma levels of growth differentiation factor-15 and renal function in the elderly: Korean frailty and aging cohort study. Kidney Blood Press Res 2019; 44: 405-14.","DOI":"10.1159\/000498959"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Mirna M, Topf A, Wernly B, <i>et al<\/i>. Novel biomarkers in patients with chronic kidney disease: An analysis of patients enrolled in the gckd-study. J Clin Med 2020; 9: 886.","DOI":"10.3390\/jcm9030886"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kaiser H, Wang X, Kvist-Hansen A, <i>et al<\/i>. Biomarkers of subclinical atherosclerosis in patients with psoriasis. Sci Rep 2021; 11: 21438.","DOI":"10.1038\/s41598-021-00999-9"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Martinez CH, Freeman CM, Nelson JD, <i>et al<\/i>. GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease. Respir Res 2017; 18: 42.","DOI":"10.1186\/s12931-017-0521-1"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kiss LZ, Ny\u00e1r\u00e1dy BB, P\u00e1llinger \u00c9, <i>et al<\/i>. Association of growth and differentiation factor-15 with coronary artery calcium score and ankle-brachial index in a middle-aged and elderly caucasian population sample free of manifest cardiovascular disease. Geroscience 2024; 46: 1343-50.","DOI":"10.1007\/s11357-023-00899-y"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Laucyte-Cibulskiene A, Ward LJ, Ebert T, <i>et al<\/i>. Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: Focus on sex-specific associations with vascular outcomes and all-cause mortality. Biol Sex Differ 2021; 12: 50.","DOI":"10.1186\/s13293-021-00393-0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Saito Y, Kobayashi Y, Fujii K, <i>et al<\/i>. Clinical expert consensus document on standards for measurements and assessment of intravascular ultrasound from the japanese association of cardiovascular intervention and therapeutics. Cardiovasc Interv Ther 2020; 35: 1-12.","DOI":"10.1007\/s12928-019-00625-6"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Kawasaki M, Takatsu H, Noda T, <i>et al<\/i>. In vivo quantitative tissue characterization of human coronary arterial plaques by use of integrated backscatter intravascular ultrasound and comparison with angioscopic findings. Circulation 2002; 105: 2487-92.","DOI":"10.1161\/01.CIR.0000017200.47342.10"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ohota M, Kawasaki M, Ismail TF, Hattori K, Serruys PW, Ozaki Y. A histological and clinical comparison of new and conventional integrated backscatter intravascular ultrasound (IB-IVUS). Circ J 2012; 76: 1678-86.","DOI":"10.1253\/circj.CJ-11-1157"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Verschuren WM, Jacobs DR, Bloemberg BP, <i>et al<\/i>. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA 1995; 274: 131-6.","DOI":"10.1001\/jama.274.2.131"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ogita M, Funayama H, Nakamura T, <i>et al<\/i>. Plaque characterization of non-culprit lesions by virtual histology intravascular ultrasound in diabetic patients: Impact of renal function. J Cardiol 2009; 54: 59-65.","DOI":"10.1016\/j.jjcc.2009.03.008"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kono K, Fujii H, Nakai K, <i>et al<\/i>. Composition and plaque patterns of coronary culprit lesions and clinical characteristics of patients with chronic kidney disease. Kidney Int 2012; 82: 344-51.","DOI":"10.1038\/ki.2012.118"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kashiyama K, Sonoda S, Muraoka Y, <i>et al<\/i>. Coronary plaque progression of non-culprit lesions after culprit percutaneous coronary intervention in patients with moderate to advanced chronic kidney disease: Intravascular ultrasound and integrated backscatter intravascular ultrasound study. Int J Cardiovasc Imaging 2015; 31: 935-45.","DOI":"10.1007\/s10554-015-0633-y"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Bundy JD, Cai X, Scialla JJ, <i>et al<\/i>. Serum calcification propensity and coronary artery calcification among patients with CKD: The CRIC (Chronic Renal Insufficiency Cohort) study. Am J Kidney Dis 2019; 73: 806-14.","DOI":"10.1053\/j.ajkd.2019.01.024"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Stomp\u00f3r T. Coronary artery calcification in chronic kidney disease: An update. World J Cardiol 2014; 6: 115-29.","DOI":"10.4330\/wjc.v6.i4.115"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Lanzer P, Boehm M, Sorribas V, <i>et al<\/i>. Medial vascular calcification revisited: Review and perspectives. Eur Heart J 2014; 35: 1515-25.","DOI":"10.1093\/eurheartj\/ehu163"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Zazzeroni L, Faggioli G, Pasquinelli G. Mechanisms of arterial calcification: The role of matrix vesicles. Eur J Vasc Endovasc Surg 2018; 55: 425-32.","DOI":"10.1016\/j.ejvs.2017.12.009"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Mathew RO, Bangalore S, Lavelle MP, <i>et al<\/i>. Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: A review. Kidney Int 2017; 91: 797-807.","DOI":"10.1016\/j.kint.2016.09.049"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Jimbo R, Kawakami-Mori F, Mu S, <i>et al<\/i>. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of klotho deficiency. Kidney Int 2014; 85: 1103-11.","DOI":"10.1038\/ki.2013.332"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Rusanescu G, Weissleder R, Aikawa E. Notch signaling in cardiovascular disease and calcification. Current Cardiol Rev 2008; 4: 148-56.","DOI":"10.2174\/157340308785160552"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Schwarz U, Buzello M, Ritz E, <i>et al<\/i>. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 2000; 15: 218-23.","DOI":"10.1093\/ndt\/15.2.218"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Demer LL, Tintut Y. Vascular calcification: Pathobiology of a multifaceted disease. Circulation 2008; 117: 2938-48.","DOI":"10.1161\/CIRCULATIONAHA.107.743161"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Schlittenhardt D, Schober A, Strelau J, <i>et al<\/i>. Involvement of growth differentiation factor-15\/macrophage inhibitory cytokine-1 (GDF-15\/MIC-1) in oxldl-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions. Cell Tissue Res 2004; 318: 325-33.","DOI":"10.1007\/s00441-004-0986-3"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Nair V, Robinson-Cohen C, Smith MR, <i>et al<\/i>. Growth differentiation factor-15 and risk of CKD progression. J Am Soc Nephrol 2017; 28: 2233-40.","DOI":"10.1681\/ASN.2016080919"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Wang J, Wei L, Yang X, Zhong J. Roles of growth differentiation factor 15 in atherosclerosis and coronary artery disease. J Am Heart Assoc 2019; 8: e012826.","DOI":"10.1161\/JAHA.119.012826"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Wollert KC, Kempf T, Lagerqvist B, <i>et al<\/i>. Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non st-elevation acute coronary syndrome. Circulation 2007; 116: 1540-8.","DOI":"10.1161\/CIRCULATIONAHA.107.697714"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Wollert KC, Kempf T, Peter T, <i>et al<\/i>. Prognostic value of growth-differentiation factor-15 in patients with non-st-elevation acute coronary syndrome. Circulation 2007; 115: 962-71.","DOI":"10.1161\/CIRCULATIONAHA.106.650846"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Rohatgi A, Patel P, Das SR, <i>et al<\/i>. Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: Observations from the dallas heart study. Clin Chem 2012; 58: 172-82.","DOI":"10.1373\/clinchem.2011.171926"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Damman P, Kempf T, Windhausen F, <i>et al<\/i>. Growth-differentiation factor 15 for long-term prognostication in patients with non-st-elevation acute coronary syndrome: An invasive versus conservative treatment in unstable coronary syndromes (ICTUS) substudy. Int J Cardiol 2014; 172: 356-63.","DOI":"10.1016\/j.ijcard.2014.01.025"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Farhan S, Freynhofer MK, Brozovic I, <i>et al<\/i>. Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study. Cardiovasc Diabetol 2016; 15: 60.","DOI":"10.1186\/s12933-016-0375-8"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Hsu LA, Wu S, Juang JJ, <i>et al<\/i>. Growth differentiation factor 15 may predict mortality of peripheral and coronary artery diseases and correlate with their risk factors. Mediators Inflamm 2017; 2017: 9398401.","DOI":"10.1155\/2017\/9398401"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Eggers KM, Kempf T, Wallentin L, Wollert KC, Lind L. Change in growth differentiation factor 15 concentrations over time independently predicts mortality in community-dwelling elderly individuals. Clin Chem 2013; 59: 1091-8.","DOI":"10.1373\/clinchem.2012.201210"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Yazawa H, Fukuda T, Kaneda H, <i>et al<\/i>. Association of serum growth differentiation factor-15 with egfr and hemoglobin in healthy older females. Int J Cardiol Heart Vasc 2020; 31: 100651.","DOI":"10.1016\/j.ijcha.2020.100651"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/66\/4\/66_24-712\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:17:34Z","timestamp":1754108254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/66\/4\/66_24-712\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.24-712","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"article-number":"24-712"}}